Gelteq Limited/$GELS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Gelteq Limited
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
- Ticker
- $GELS
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Clayton, Australia
- Website
- www.gelteq.com
Gelteq Limited Metrics
BasicAdvanced
$4.7M
-
-$0.48
-
-
Price and volume
Market cap
$4.7M
52-week high
$2.01
52-week low
$0.39
Average daily volume
74K
Financial strength
Current ratio
0.091
Quick ratio
0.072
Long term debt to equity
0.001
Total debt to equity
0.36
Interest coverage (TTM)
-2.93%
Profitability
EBITDA (TTM)
-3.514
Gross margin (TTM)
75.54%
Net profit margin (TTM)
-1,501.32%
Operating margin (TTM)
-1,351.12%
Management effectiveness
Return on assets (TTM)
-17.61%
Return on equity (TTM)
-42.93%
Valuation
Price to revenue (TTM)
13.303
Price to book
0.33
Price to tangible book (TTM)
-0.92
Price to free cash flow (TTM)
-1.847
Free cash flow yield (TTM)
-54.15%
Free cash flow per share (TTM)
-0.228
Growth
Revenue change (TTM)
153.17%
Earnings per share change (TTM)
13.93%
Gelteq Limited Financial Performance
Revenues and expenses
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.